tradingkey.logo

Globus Medical Inc

GMED
View Detailed Chart

57.840USD

-0.400-0.69%
Close 09/16, 16:00ETQuotes delayed by 15 min
7.81BMarket Cap
21.90P/E TTM

Globus Medical Inc

57.840

-0.400-0.69%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.69%

5 Days

-2.10%

1 Month

-4.51%

6 Months

-18.58%

Year to Date

-30.07%

1 Year

-17.34%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-16

Key Insights

The company's fundamentals are relatively weak. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
49 / 207
Overall Ranking
149 / 4724
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 15 analysts
Buy
Current Rating
82.545
Target Price
+41.73%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 146.31% year-on-year.
Undervalued
The company’s latest PE is 22.05, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 115.30M shares, decreasing 9.77% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 10.68M shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Ticker SymbolGMED
CompanyGlobus Medical Inc
CEOMr. Keith W. Pfeil
Websitehttps://www.globusmedical.com/
KeyAI